Luminex logo

LMNX - Luminex News Story

$36.72 -0.1  -0.4%

Last Trade - 7:46pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.22bn
Enterprise Value £1.14bn
Revenue £298.7m
Position in Universe 2387th / 6858

BRIEF-Luminex Corporation Reports Q3 Loss Per Share $0.12

Mon 4th November, 2019 9:40pm
Nov 4 (Reuters) - Luminex Corp  LMNX.O :
    * ORATION REPORTS THIRD QUARTER 2019 RESULTS AND SUBMISSION
OF
VERIGENE II GASTROINTESTINAL FLEX ASSAY TO THE FDA
    * Q3 LOSS PER SHARE $0.12
    * Q3 REVENUE $78.7 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$81.8
MILLION
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.03 - REFINITIV IBES
DATA
    * FOR FY 2019, COMPANY IS ADJUSTING ITS REVENUE EXPECTATIONS
TO A
RANGE OF $334 MILLION TO $337 MILLION
    * FY2019 REVENUE VIEW $340.3 MILLION - REFINITIV IBES DATA

Source text for Eikon:  ID:nPn91bgtSa 
Further company coverage:  LMNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.